AU2195395A - Synthetic peptide based immunogens for the treatment of allergy - Google Patents

Synthetic peptide based immunogens for the treatment of allergy

Info

Publication number
AU2195395A
AU2195395A AU21953/95A AU2195395A AU2195395A AU 2195395 A AU2195395 A AU 2195395A AU 21953/95 A AU21953/95 A AU 21953/95A AU 2195395 A AU2195395 A AU 2195395A AU 2195395 A AU2195395 A AU 2195395A
Authority
AU
Australia
Prior art keywords
gly
lys
phe
val
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21953/95A
Other languages
English (en)
Inventor
Chang Yi Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Biomedical Inc
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of AU2195395A publication Critical patent/AU2195395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU21953/95A 1994-03-28 1995-03-24 Synthetic peptide based immunogens for the treatment of allergy Abandoned AU2195395A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21846194A 1994-03-28 1994-03-28
US218461 1994-03-28
US32891294A 1994-10-25 1994-10-25
US328912 1994-10-25
PCT/US1995/003741 WO1995026365A1 (en) 1994-03-28 1995-03-24 Synthetic peptide based immunogens for the treatment of allergy

Publications (1)

Publication Number Publication Date
AU2195395A true AU2195395A (en) 1995-10-17

Family

ID=26912926

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21953/95A Abandoned AU2195395A (en) 1994-03-28 1995-03-24 Synthetic peptide based immunogens for the treatment of allergy

Country Status (6)

Country Link
EP (1) EP0811016A1 (enExample)
JP (1) JPH09510975A (enExample)
CN (1) CN1146772A (enExample)
AU (1) AU2195395A (enExample)
CA (1) CA2186595A1 (enExample)
WO (1) WO1995026365A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843462A (en) * 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
HUP9901109A3 (en) 1996-03-01 1999-11-29 Novartis Ag Peptide immunogens for vaccination against and treatment of allergy
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
EP1037663A2 (en) 1997-12-16 2000-09-27 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
US6090388A (en) * 1998-06-20 2000-07-18 United Biomedical Inc. Peptide composition for prevention and treatment of HIV infection and immune disorders
TWI227241B (en) * 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
MXPA01010625A (es) 1999-04-23 2003-09-04 Pharmexa As Metodo para regulacion por disminucion de la actividad de interleucina 5.
GB9913327D0 (en) * 1999-06-08 1999-08-11 Smithkline Beecham Biolog Vaccine
US6846486B1 (en) 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
EP1305339A2 (en) * 2000-03-15 2003-05-02 Heska Corporation 3d model of an fc epsilon receptor alpha chain-ige fc region complex
AU7658101A (en) * 2000-07-28 2002-02-13 Cytos Biotechnology Ag Compositions for inducing self-specific anti-ige antibodies and uses thereof
US20020172673A1 (en) * 2000-09-06 2002-11-21 Pharmexa A/S Method for down-regulating IgE
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
JP2003047482A (ja) * 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
US7604955B2 (en) 2001-08-13 2009-10-20 Swey-Shen Alex Chen Immunoglobulin E vaccines and methods of use thereof
IL158287A0 (en) * 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
US8697846B2 (en) * 2007-08-15 2014-04-15 Emory University Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (F-PEAT) technology
CA2717930A1 (en) * 2008-03-13 2009-09-17 Yossef Kliger Novel gp96 derived peptides
DK2788021T3 (en) 2011-12-09 2017-04-10 Bavarian Nordic As POXVIRUS VECTOR FOR EXPRESSION OF BACTERIAL ANTIGENES CONNECTED TO TETANANOX INFRAGMENT C
US9187553B2 (en) * 2012-01-25 2015-11-17 Swey-Shen Chen Displaying native human IgE neutralizing FcepsilonRIa-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold
US9657071B2 (en) * 2012-06-18 2017-05-23 Nippon Zenyaku Kogyo Co., Ltd. IgE peptide vaccine
EP2790442A1 (en) 2013-04-09 2014-10-15 Alcatel Lucent Control system, apparatus, methods, and computer readable storage medium storing instructions for a network node and/or a network controller
CN112237638B (zh) * 2020-10-28 2022-11-29 西安华牧生物科技有限责任公司 降低放射性核素肾浓聚的组合探针及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5552537A (en) * 1993-03-24 1996-09-03 The Regents Of The University Of California IgE isoforms and methods of use
ATE221387T1 (de) * 1993-04-27 2002-08-15 United Biomedical Inc Immunogene lhrh peptidkonstrukion und synthetische, universale immunstimulatoren als impfstoffe
GB9320897D0 (en) * 1993-10-11 1993-12-01 Peptide Therapeutics Ltd Compounds useful in anti-allergy treatment
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds

Also Published As

Publication number Publication date
CN1146772A (zh) 1997-04-02
EP0811016A4 (enExample) 1997-12-10
CA2186595A1 (en) 1995-10-05
WO1995026365A1 (en) 1995-10-05
EP0811016A1 (en) 1997-12-10
JPH09510975A (ja) 1997-11-04

Similar Documents

Publication Publication Date Title
AU2195395A (en) Synthetic peptide based immunogens for the treatment of allergy
EP1090039B1 (en) Peptide composition as immunogen for the treatment of allergy
CA2329772C (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
US5759551A (en) Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
EP0708656B1 (en) Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
WO1994025060A9 (en) Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
EP1087787A1 (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
AU4012095A (en) Synthetic ige membrane anchor peptide immunogens for the treatment of allergy
WO2002051860A2 (en) Synthetic peptide composition as immunogens for prevention of urinary tract infection
Wang B cell & T cell epitope orientation and adjuvant-free immunization in synthetic vaccine design
HK1036804B (en) Peptide composition as immunogen for the treatment of allergy
HK1143950B (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
HK1037860B (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
MXPA00011938A (en) Peptide composition as immunogen for the treatment of allergy
MXPA00011939A (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptideimmunogens